MedTrace Logo

Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation

NCT06158971 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-04-04

No results posted yet for this study

Summary

Evaluation of safety and technical feasibility of the phenoWave MW Ablation System for microwave ablation of lesions in the lung.

Conditions

  • Lung Neoplasm

Interventions

DEVICE

Flexible Bronchoscopic Microwave Ablation

The phenoWave flexible microwave ablation system will be used to perform soft tissue ablation in the lungs under image guidance.

Sponsors & Collaborators

  • NIH/NCI - Grant award number: R01CA218357

    collaborator UNKNOWN

  • phenoMapper, LLC

    lead INDUSTRY

Principal Investigators

  • Daniel Steinfort, MBBS, BMedSci, FRACP, PhD · Melbourne Health

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2025-01-31
Completion
2025-01-31
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06158971 on ClinicalTrials.gov